Vorinostat Completed Phase 1 Trials for Pelvic Cancer / Radiotherapy Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00455351Vorinostat and Palliative Radiotherapy